The numbers for 2024 have been tabulated, and we are thrilled to share a landmark achievement for the field: more than ONE MILLION patients have been treated worldwide with focused ultrasound.
The leading treatment indications include uterine fibroids and adenomyosis, essential tremor, Parkinson’s disease, Alzheimer’s disease, and tumors of the liver, prostate, and pancreas. This incredible milestone reflects the growing recognition of focused ultrasound as a game-changing, noninvasive therapy that is transforming patient care across a wide range of serious conditions. Please note that the treatment numbers are based on reporting from focused ultrasound manufacturers and likely represent a conservative estimate of the actual total number of patients treated.
The Foundation is proud to have played a role in advancing the field, accelerating research, fostering collaboration, and supporting the development of new treatments. But this achievement is a testament to the dedication of researchers, clinicians, industry partners, and supporters like you who have helped move the field forward.